D. J. Richel

Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer

Jolien Tol, Miriam Koopman, Annemieke Cats et al. · New England Journal of Medicine · 2009 · 1.4K citations · Full text

Medicine, Oncology, Pharmacology +16

Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study

J. Schouten, Ferdinand W.N.M. Wit, Ineke G. Stolte et al. · Clinical Infectious Diseases · 2014 · 774 citations · Full text

Public Health, Geriatric Medicine, Aging +13

Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study

Hedy L. Kindler, Tatsuya Ioka, D. J. Richel et al. · The Lancet Oncology · 2011 · 396 citations

Medicine, Oncology, Pharmacology +7

A single‐arm, multicenter, open‐label phase 2 study of lapatinib as the second‐line treatment of patients with locally advanced or metastatic transitional cell carcinoma

Christian Wülfing, Jean‐Pascal Machiels, D. J. Richel et al. · Cancer · 2009 · 215 citations · Full text

Medicine, Oncology, Pharmacology +16

A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia.

Bertram Wiedenmann, Peter Malfertheiner, Helmut Friess et al. · PubMed · 2008 · 144 citations

Medicine, Oncology, Pharmacotherapy +16